Skip to main content

Journals in Pharmacology

61-70 of 72 results in All results

SLAS Discovery

  • ISSN: 2472-5552
Advancing the Science of Drug DiscoveryAn official journal of SLAS SLAS Discovery reports how scientists develop and use novel technologies and/or approaches to provide and characterize chemical and biological tools to understand and treat human disease. The journal focuses on drug discovery sciences with a strong record of scientific rigor and impact, reporting on research that: Enables and improves target validation Evaluates current drug discovery technologies Provides novel research tools Incorporates research approaches that enhance depth of knowledge and drug Discovery success SLAS Discovery's Editorial Scope Includes: scientific and technical advances in target identification/validation (including chemical probes, RNA silencing, gene editing technologies); biomarker discovery; assay development; virtual, medium- or high-throughput screening (biochemical and biological, biophysical, phenotypic, toxicological, ADME); lead generation/optimization; chemical biology; and informatics (data analysis, image analysis, statistics, bio- and chemo-informatics). Review articles cover new paradigms in drug discovery and advances in drug discovery technologies. SLAS Discovery is of particular interest to those involved in analytical chemistry, applied microbiology, automation, biochemistry, bioengineering, biomedical optics, biotechnology, bioinformatics, cell biology, DNA science and technology, genetics, information technology, medicinal chemistry, molecular biology, natural products chemistry, organic chemistry, pharmacology, spectroscopy, and toxicology.
SLAS Discovery

Schizophrenia Research

  • ISSN: 0920-9964
  • 5 Year impact factor: 4.4
  • Impact factor: 4.5
An International Multidisciplinary Journal of the Schizophrenia International Research Society As official journal of the Schizophrenia International Research Society (SIRS) Schizophrenia Research is THE journal of choice for international researchers and clinicians to share their work with the global schizophrenia research community. More than 6000 institutes have online or print (or both) access to this journal - the largest specialist journal in the field, with the largest readership! Schizophrenia Research's time to first decision is as fast as 6 weeks and its publishing speed is as fast as 4 weeks until online publication (corrected proof/Article in Press) after acceptance and 14 weeks from acceptance until publication in a printed issue. The journal publishes novel papers that really contribute to understanding the biology and treatment of schizophrenic disorders; Schizophrenia Research brings together biological, clinical and psychological research in order to stimulate the synthesis of findings from all disciplines involved in improving patient outcomes in schizophrenia. Manuscripts with a focus on cognition in schizophrenia can be submitted to the journal?s open access companion title, Schizophrenia Research: Cognition.
Schizophrenia Research

Sleep Science

  • ISSN: 1984-0063
The journal is transferring to the Brazilian Association of Sleep per January 1st, 2017. The journal is not accepting new submissions at the moment. Should you have any queries please contact the Managing Editor Lenise Kim: [email protected] SLEEP SCIENCE is the official journal of the Brazilian Association of Sleep (ABS - Associação Brasileira de Sono) and Latin American Federation of Sleep Societies (FLASS - Federación Latinoamericana de Sociedades de Sueño). It is an international, interdisciplinary and open access journal dedicated to investigation of sleep, chronobiology, and related topics. The journal welcomes original studies, reviews, short communications, theoretical essays and case reports in both pre-clinical and clinical research. Research areas include: - Sleep physiology and mechanisms; - Sleep deprivation, sleep restriction, and shift work; - Sleep disturbances, such as Sleep Apnea, Insomnia, Narcolepsy, etc; - Chronobiology, melatonin and clock genes.
Sleep Science

TIP

  • ISSN: 1405-888X
TIP is a semiannual periodical specialized in Chemical-Biological Sciences, edited by the Publishing Department in FES Zaragoza, UNAM. It has a public resources funding. Its editing formats are PDF and XML. This periodical is mainly addressed to researchers, professionals and students interested in the development of chemical-biological sciences. Its aim is to disseminate information in the following areas: Cellular and Molecular Biology, Microbiology, Genetics, Physiology, Toxicology, Biochemistry, Biophysics, Biotechnology, Botany and Zoology, Ethology, Ecology, Soil Science, Geology, Geophysics, Environmental Geochemistry, Global Warming, Paleontology, Archaeozoology and Evolution, Pharmacy, Physical Chemistry, Physiochemical, as well as, General, Organic, Inorganic, Molecular and Industrial Chemistry. This periodical publishes mainly papers about original unpublished scientific research, but also educational reports, reviews and essays of different types, as well as, the results from research projects of graduate students. TIP is currently indexed in: PERIÓDICA. LATINDEX, ARTEMISA, REDALyC, SciELO-México, Master Journal List de Thomson Reuters ISI, Zoological Record, Portal de Revistas Científicas y Arbitradas de UNAM, EBSCO Information Services and Chemical Abstracts Service. TIP es una publicación semestral especializada en ciencias químico-biológicas, editada por el departamento de publicaciones de la FES Zaragoza, UNAM y cuyo financiamiento es con recursos públicos. Los formatos de edición son en PDF y XML. Está dirigida fundamentalmente a investigadores, profesionistas y estudiantes interesados en el avance de las disciplinas químico-biológicas. El objetivo es difundir información en: biología celular y molecular, microbiología, genética, fisiología, toxicología, bioquímica, biofísica, biotecnología, botánica y zoología, etología, ecología, edafología, geología, geofísica, geoquímica ambiental, cambio climático, paleontología, arqueozoología y evolución, farmacia, fisicoquímica, química general, orgánica, inorgánica, molecular e industrial. La revista es una publicación que acepta principalmente trabajos de investigación científica original e inédita, pero también artículos de revisión, ensayos, notas científicas y los resultados de investigaciones de tesis de estudiantes de grado, debidamente asesorados. TIP está actualmente indexada en: PERIÓDICA. LATINDEX, ARTEMISA, REDALyC, SciELO-México, Master Journal List de Thomson Reuters ISI, Zoological Record, Portal de Revistas Científicas y Arbitradas de UNAM, EBSCO Information Services y Chemical Abstracts Service.
TIP

The Egyptian Heart Journal

  • ISSN: 1110-2608
As of 1 January 2019 the journal has been transferred to the new Publisher, Springer Nature. The Egyptian Heart Journal aims to publish the highest quality material, both clinical and scientific, on all aspects of Cardiovascular Medicine. It includes articles related to research findings, technical evaluations, and reviews. In addition it provides a forum for the exchange of information on all aspects of Cardiovascular Medicine, including educational issues.The Egyptian Heart Journal is an international, English language, peer-reviewed journal concerned with Cardiovascular Medicine. It is an official Journal of the Egyptian Society of Cardiology and is published quarterly. Papers submitted to these journals which do not adhere to the Instructions for Authors will be returned for appropriate revision to be in line with the Instructions for Authors. They may then be re-submitted. For queries related to the journal, please contact [email protected]
The Egyptian Heart Journal

The Journal of Nutritional Biochemistry

  • ISSN: 0955-2863
  • 5 Year impact factor: 5.9
  • Impact factor: 5.6
Devoted to advancements in nutritional sciences, The Journal of Nutritional Biochemistry presents experimental nutrition research as it relates to: biochemistry, molecular biology, toxicology, immunology or physiology and human health and diseases. Rigorous reviews by an international editorial board of distinguished scientists ensure publication of the most current and key research being conducted in nutrition at the cellular, animal and human level. In addition to its monthly features of critical reviews and research articles, The Journal of Nutritional Biochemistry also periodically publishes emerging issues, experimental methods, and other types of articles such as but not limited to policy statements.
The Journal of Nutritional Biochemistry

The Lancet

  • ISSN: 0140-6736
  • 5 Year impact factor: 118.1
  • Impact factor: 168.9
The Lancet is an independent, international general medical journal founded in 1823 by Thomas Wakley. Since its first weekly issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people. The Lancet is committed to applying scientific knowledge to improve health and advance human progress. In our weekly issues, and Online First content, we publish some of the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health.
The Lancet

Therapies

  • ISSN: 0040-5957
  • 5 Year impact factor: 2.1
  • Impact factor: 2.6
Official publication of the Société Française de Pharmacologie et de Thérapeutique (SFPT) – Organe officiel de la Société Française de Pharmacologie et de Thérapeutique (SFPT) Therapies is a peer-reviewed journal devoted to Clinical Pharmacology, Therapeutics, Pharmacokinetics, Pharmacovigilance, Addictovigilance, Social Pharmacology, Pharmacoepidemiology, Pharmacoeconomics and Evidence-Based-Medicine. Thérapie publishes in French or in English original articles, general reviews, letters to the editor reporting original findings, correspondence relating to articles or letters published in the Journal, short articles, editorials on up-to-date topics, Pharmacovigilance or Addictovigilance reports that follow the French "guidelines" concerning good practice in pharmacovigilance publications. The journal also publishes thematic issues on topical subject. The journal is indexed in the main international data bases and notably in: Biosis Previews/Biological Abstracts, Embase/Excerpta Medica, Medline/Index Medicus, Science Citation Index. Thérapies est un journal bimensuel consacré à des sujets de pharmacologie clinique, de thérapeutique, de pharmacocinétique, de pharmacovigilance, d'addictovigilance, de pharmacologie sociale, de pharmacoépidémiologie, de pharmacoéconomie ou de médecine factuelle. La revue publie en langue française ou anglaise des mémoires originaux, des revues générales, des lettres à la rédaction exposant des faits originaux, des correspondances à propos d'articles ou de lettres publiés dans la revue, des observations de pharmacovigilance et d'addictovigilance répondant aux normes des bonnes pratiques de publication. Elle propose également des comptes rendus et actes de congrès, et des numéros à thème en rapport avec l'actualité. Thérapies est indexé dans les principales bases de données biomédicales: Biosis Previews/Biological Abstracts, Embase/Excerpta Medica, Medline/Index Medicus, Science Citation Index.
Therapies

Toxicology Letters

  • ISSN: 0378-4274
  • 5 Year impact factor: 3.8
  • Impact factor: 3.5
Official Journal of EUROTOX An international journal for the rapid publication of novel reports on a range of aspects of toxicology, especially mechanisms of toxicity. Toxicology Letters serves as a multidisciplinary forum for research in toxicology. The prime aim is the rapid publication of research studies that are both novel and advance our understanding of a particular area. In addition to hypothesis-driven studies on mechanisms of mammalian toxicity, Toxicology Letters welcomes seminal work in the following areas: In silico toxicology Toxicokinetics Physiologically-based pharmacokinetic (PBPK) modeling Systems toxicology Predictive toxicology 3R research in toxicology New approach methodology (NAMs) Adverse outcome pathways (AOPs) Integrated testing strategies Systematic and narrative reviews and mini-reviews in various areas of toxicology will be published. Clinical, occupational and safety evaluation, hazard and risk assessment, regulatory toxicology, impact on man, animal and environment studies of sufficient novelty to warrant rapid publication will be considered. Toxicology Letters also publishes editorials, commentaries and contemporary issues in toxicology. The following types of work are not within the scopes of Toxicology Letters: Ecotoxicology studies Case studies Chemoprevention studies Pharmacological investigations Authors are advised to follow the ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments; https://arriveguidelines.org/) and the OECD guidance document on Good In Vitro Method Practices (GIVIMP; https://www.oecd.org/env/guidance-document-on-good-in-vitro-method-practices-givimp-9789264304796-en.htm). In vitro or in vivo investigations conducted at concentrations or doses of no relevance to human or animal exposure will not be considered. Routes of exposure other than those relevant to human or animal exposure need to be justified. Assessment of dose-response should be an integral component of any toxicological research report. Unless adequately justified, studies conducted at a single dose level may not be considered. Test materials must be chemically defined and characterized. Investigations of chemically undefined plant extracts or uncharacterized nanoparticles will not be considered.
Toxicology Letters

Toxicology and Applied Pharmacology

  • ISSN: 0041-008X
  • 5 Year impact factor: 4
  • Impact factor: 3.8
Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products.Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of-the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged.Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article.TAAP also issues a standing call for outstanding Invited Review Articles. Potential authors should contact the Editor-In-Chief and complete an Invited Review Proposal Form before preparing or submitting their Review Article. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Toxicology and Applied Pharmacology